Emcure Pharma Gains After Kotak Instl Equities Upgrades It To Buy With Target Of ₹1,680 | CNBC TV18

Emcure Pharma gains after Kotak Instl Equities upgrade the stock to Buy from Add, says they expect a pick-up in organic growth in H2FY25. Vamakshi Dhoria with more details.

#emcurepharma #buzzingstocks #stockmarket #stockmarketnews #stockmarketupdates #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday

🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
👑 Check Out Top CNBC TV18 Playlist Videos:


🔹YoungTurks Reloaded:    • Young Turks Reloaded with Shereen Bhan  

🔹CNBC TV18 Digital Podcast:    • I Did It My Way - CNBC TV18 Digital P...  

🔹Sounding Board:    • Sounding Board | CNBC TV18  

🔹International Videos:    • World News - CNBC-TV18  

🔹CNBC TV18 Market Cafe:    • CNBC TV18 Market Cafe  

🔹CNBC TV18 Digital:    • CNBC-TV18 Digital Videos  

🔹CNBC TV18 Weekend Special:    • CNBC-TV18 Weekend Special  

🔹CNBC TV18 Next-Gen:    • CNBCTV18 Next-Gen  

🔹Overdrive Show:    • OVERDRIVE || CNBC TV18  

🔹Young Turks:    • YOUNG TURKS - The Entrepreneurship Show  

🔹Startup Streets:    • Startup Street  

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook:   / cnbctv18india  
Follow us on Twitter:   / cnbctv18news  
Follow us on Instagram:   / cnbctv18india  
Catch us on: Linkedin:   / cnbc-tv18  
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.